세계의 오가노이드와 스페로이드 시장 규모 조사 및 예측 : 유형별, 방법별, 최종사용자별, 지역별 분석(2023-2030년)

Global Organoids and Spheroids Market is valued at approximately USD 560.51 million in 2022 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2023-2030. Organoids and spheroids represent advanced three-dimensional (3D) cell culture models extensively employed in scientific research, spanning regenerative medicine, drug discovery, and disease modelling domains. Organoids are complex and self-organizing structures that are developed from stem cells or tissue-specific progenitor cells, closely replicating the architecture and functionality of specific organs or tissues. This model is derived from various cell types and provides a nuanced platform for investigating organ development, disease mechanisms, drug toxicity, and personalized medicine. Whereas spheroids are cell aggregates that spontaneously form spherical shapes under specific culture conditions. Spheroids are instrumental in studying cell behaviour, drug responses, tumour biology, and tissue engineering widely derived from diverse cell types. Both organoids and spheroids offer researchers more physiologically relevant environments than traditional 2D cell cultures and present as an essential bridge between simplified models and the complexities of in vivo systems. The Organoids and Spheroids Market are being driven by factors including increasing demand for personalized drugs, growing investments in R&D activities, and a rise in the shift towards organoid 3D cell cultures for cancer research. . Furthermore, the expanding adoption of organoid technology across various applications such as genetic mutation analysis, gene assessment, and tumour modelling is poised to propel the demand for organoids globally.

In addition, the increasing prevalence of chronic diseases like cancer, diabetes, and neurological disorders is also exhibiting a positive influence on market growth across the world. Organoids and spheroids, advanced 3D models, closely mimic human tissue structures, enabling precise disease studies and treatment testing. They facilitate personalized medicine development by analyzing patient-specific responses to drugs. According to World Health Organization (WHO) data published in April 2021, chronic diseases are expected to kill 41 million people each year, equivalent to 71% of all deaths globally. In low- and middle-income countries chronic disease death are accounted for 77%. Additionally, these models streamline drug discovery processes and offer insights into disease pathways, aiding in the identification of therapeutic targets. Moreover, in tissue engineering and regenerative medicine, organoids and spheroids hold promise for developing functional tissue substitutes to address organ damage caused by chronic diseases. Overall, the rising incidence of chronic diseases underscores the significance of organoids and spheroids in advancing disease understanding and treatment development. Moreover, the growing field of cell therapy and tissue engineering, as well as the increasing technological advancements in 3D spheroid technologies presents various lucrative opportunities over the forecasting years. However, the challenges associated with 3D cell culturing and ethical issues associated with organoid & spheroid cultures are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Organoids and Spheroids Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing technological advancements by pharmaceutical and biotechnology companies, a rise in focus on biopharmaceutical R&D, as well as surging production of medicines and drug discovery. Whereas Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rise in advancements in 3D cell culture technology, increasing healthcare spending, and ongoing advancements in stem cell research are significantly propelling the market demand across the region. Increasing collaborations among key market players are anticipated to bolster market expansion. For instance, in March 2020, Nichirei Biosciences and UPM Biomedicals joined forces to offer UPM culture products in Japan, thus improving the accessibility of natural hydrogels for spheroid and organoid culture.

Major market players included in this report are:

• InSphero AG
• Lonza Group
• PeproTech Inc.
• Greiner AG
• STEMCELL Technologies Inc.
• Corning Inc.
• Cellesce Ltd.
• Perkin Elmer Inc.
• Merck KGaA
• Thermofisher Scientific Inc.

Recent Developments in the Market:

• In August 2023, InSphero, a company renowned for its expertise in robotics and intelligent automation announced a distribution agreement with Advanced BioMatrix, a leading provider of biomaterial solutions for cellular assays and regenerative medicine. The collaboration aims to extend the application of 3D cell culture techniques beyond conventional suspension-based methods, focusing on the incorporation of scaffold-based models.
• In June 2023, Inventia Life Science formed a strategic partnership with Biotron Healthcare to distribute its RASTRUM miniaturized 3D cell culturing platform across India. This partnership aims to enhance the field of organoids and spheroids by increasing the accessibility of the advanced technology offered by the RASTRUM platform to researchers across India.
• in June 2023, AMSBIO launched Matrimix, a novel 3D cell culture substrate featuring a fully defined formulation and it enables researchers to grow a range of tissues. It offers a dependable and constant extracellular matrix for cell growth, this novel product should aid in the study of organoids and spheroid.

Global Organoids And Spheroids Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Type, Method, End-user, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Organoids Type
• Spheroids Type

By Method:

• Extracellular Matrix Scaffold Method
• Spinning Bioreactor Method
• Hanging Drop Method
• Low Adherent Culture Plate Method
• Magnetic Levitation Method

By End-user:

• Biotechnology and Pharmaceutical Industry
• Academic and Research Institutes
• Hospitals and Diagnostic Centers

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1.Organoids and Spheroids Market, by Region, 2020-2030 (USD Million)
  • 1.2.2.Organoids and Spheroids Market, by Type, 2020-2030 (USD Million)
  • 1.2.3.Organoids and Spheroids Market, by Method, 2020-2030 (USD Million)
  • 1.2.4.Organoids and Spheroids Market, by End-user, 2020-2030 (USD Million)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Organoids and Spheroids Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Organoids and Spheroids Market Dynamics

• 3.1.Organoids and Spheroids Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing prevalence of chronic diseases
    • 3.1.1.2.Rising adoption of personalized medicines
  • 3.1.2.Market Challenges
    • 3.1.2.1.Challenges associated with 3D cell culturing
    • 3.1.2.2.Ethical issues associated with organoid & spheroid cultures
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Growing field of cell therapy and tissue engineering
    • 3.1.3.2.Increasing technological advancements in 3D spheroid technologies

Chapter 4.Global Organoids and Spheroids Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Organoids and Spheroids Market, by Type

• 5.1.Market Snapshot
• 5.2.Global Organoids and Spheroids Market by Type, Performance - Potential Analysis
• 5.3.Global Organoids and Spheroids Market Estimates & Forecasts by Type 2020-2030 (USD Million)
• 5.4.Organoids and Spheroids Market, Sub Segment Analysis
  • 5.4.1.Organoids Type
  • 5.4.2.Spheroids Type

Chapter 6.Global Organoids and Spheroids Market, by Method

• 6.1.Market Snapshot
• 6.2.Global Organoids and Spheroids Market by Method, Performance - Potential Analysis
• 6.3.Global Organoids and Spheroids Market Estimates & Forecasts by Method 2020-2030 (USD Million)
• 6.4.Organoids and Spheroids Market, Sub Segment Analysis
  • 6.4.1.Extracellular Matrix scaffold Method
  • 6.4.2.Spinning Bioreactor method
  • 6.4.3.Hanging Drop method
  • 6.4.4.Low adherent Culture plate method
  • 6.4.5.Magnetic leviation Method

Chapter 7.Organoids and Spheroids Market, by End-user

• 7.1.Market Snapshot
• 7.2.Global Organoids and Spheroids Market by End-user, Performance - Potential Analysis
• 7.3.Global Organoids and Spheroids Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
• 7.4.Organoids and Spheroids Market, Sub Segment Analysis
  • 7.4.1.Biotechnology and Pharmaceutical Industry
  • 7.4.2.Academic and Research Institutes
  • 7.4.3.Hospitals and Diagnostic Centers

Chapter 8.Global Organoids and Spheroids Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Organoids and Spheroids Market, Regional Market Snapshot
• 8.4.North America Organoids and Spheroids Market
  • 8.4.1.U.S. Organoids and Spheroids Market
    • 8.4.1.1.Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Method breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End-user breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Organoids and Spheroids Market
• 8.5.Europe Organoids and Spheroids Market Snapshot
  • 8.5.1.U.K. Organoids and Spheroids Market
  • 8.5.2.Germany Organoids and Spheroids Market
  • 8.5.3.France Organoids and Spheroids Market
  • 8.5.4.Spain Organoids and Spheroids Market
  • 8.5.5.Italy Organoids and Spheroids Market
  • 8.5.6.Rest of Europe Organoids and Spheroids Market
• 8.6.Asia-Pacific Organoids and Spheroids Market Snapshot
  • 8.6.1.China Organoids and Spheroids Market
  • 8.6.2.India Organoids and Spheroids Market
  • 8.6.3.Japan Organoids and Spheroids Market
  • 8.6.4.Australia Organoids and Spheroids Market
  • 8.6.5.South Korea Organoids and Spheroids Market
  • 8.6.6.Rest of Asia Pacific Organoids and Spheroids Market
• 8.7.Latin America Organoids and Spheroids Market Snapshot
  • 8.7.1.Brazil Organoids and Spheroids Market
  • 8.7.2.Mexico Organoids and Spheroids Market
• 8.8.Middle East & Africa Organoids and Spheroids Market
  • 8.8.1.Saudi Arabia Organoids and Spheroids Market
  • 8.8.2.South Africa Organoids and Spheroids Market
  • 8.8.3.Rest of Middle East & Africa Organoids and Spheroids Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.InSphero AG
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Lonza Group
  • 9.3.3.PeproTech Inc
  • 9.3.4.Greiner AG
  • 9.3.5.STEMCELL Technologies Inc
  • 9.3.6.Corning Inc
  • 9.3.7.Cellesce Ltd
  • 9.3.8.Perkin Elmer Inc
  • 9.3.9.Merck KGaA
  • 9.3.10.Thermofisher Scientific Inc

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption